How Do Doctors Feel About Robots in the Exam Room?

Posted by Paul Darling on Wed, Aug 29, 2018

This blog post is the first in a series on ZS’s 2018 AI in Healthcare study.

Data-rich, technology-based solutions like artificial intelligence are lining up to transform many facets of healthcare, but before we start planning for the transformation that this technology can bring, we might want to do a reality check: Will AI truly be disruptive in an industry that has been slow to adopt new technologies, or will the change be incremental? And even if AI can improve care delivery, what do doctors—and patients—think about inviting AI into the exam room?


>
Read More

How Biosimilars Follow Their Own Sales Path, in Three Case Studies

Posted by Judith Kulich on Tue, Jan 27, 2015

Here’s a problem that pharma and biotech executives (and we at ZS) are trying hard to solve: When it comes to biosimilars—the biotech drugs rated equivalent to biologic innovators—what will convince physicians, patients and payers to switch?


>
Read More